PBRM1 and nonpapillary renal cell carcinoma: Furthermore, 65 out of 85 (76.4%) ccRCC patients that were PBRM1-negative showed worse overall survival than the remaining PBRM1-positive ccRCC patients (Figure 4C), however, there was no statistically significant between two groups (P=0.07).